Amorphous solid dispersions (ASDs) are advanced pharmaceutical formulations in which a poorly water-soluble drug is dispersed within an amorphous polymer matrix. In this non-crystalline form, the drug exhibits enhanced apparent solubility. While various polymers can be considered, the optimal polymer must effectively maintain supersaturation by inhibiting drug crystallization.
Join our webinar ‘Polymer Screening for Amorphous Solid Dispersions (ASDs) using the Crystal16’ by Veranova’s Principal Scientist, Thierry Bonnaud, at 15:00 BST/10:00 EDT on Thursday, 2 October 2025.
In this webinar, hosted by Technobis, Thierry will demonstrate the application of the solvent shift method [i] as a preliminary screening tool to reduce the number of polymers selected for further evaluation. Piroxicam, a BCS Class II non steroidal anti-inflammatory drug (NSAID) with low aqueous solubility, was used as the model compound. The use of the Crystal16 system in screening polymers for piroxicam with the solvent shift method will be discussed in detail.
Register for this live webinar
